3 Best Stocks With 100%+ Upside to Buy This Week, According to Analysts
Analysts see strong momentum in some stocks this week, including Viking Therapeutics ($VKTX), USA Rare Earth ($USAR), and NextNav ($NN). While...
Viking Therapeutics Inc. (VKTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 1,605,994 | $62,649,826 | -5% | 0.03% |
| 2. | 1,220,800 | $47,623,408 | +86% | 6.02% | |
| 3. | 1,122,100 | $43,773,121 | +22% | 0.01% | |
| 4. | Citadel Investment Group Ken Griffin | 951,515 | $37,118,600 | -25% | 0% |
| 5. | Vestal Point Capital Ryan Wilder | 680,000 | $26,526,800 | -26% | 0.62% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.50 | 4,475 | $149,912.50 | 4,475 | 2026-03-10 | Filing | |
| $24.15 | 1,240 | $29,942.78 | 1,240 | 2025-03-31 | Filing | |
| $24.15 | 1,240 | $29,942.78 | 1,240 | 2025-03-31 | Filing | |
| $2.47 | 45,000 | $111,195.00 | 111,250 | 2022-05-02 | Filing | |
| $5.69 | 20,000 | $113,800.00 | 66,250 | 2021-06-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.32 | 148,517 | $4,947,888.41 | 2,572,441 | 2026-07-29 | Filing | |
| $33.47 | 21,217 | $710,141.48 | 212,204 | 2026-07-29 | Filing | |
| $33.47 | 18,217 | $609,635.55 | 422,760 | 2026-07-29 | Filing | |
| $32.09 | 1,500 | $48,133.05 | 189,891 | 2026-01-05 | Filing | |
| $34.24 | 10,300 | $352,634.92 | 191,371 | 2026-01-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,335,756 | $247,157,830 | 0.01% | |
| 2. | 6,189,649 | $241,458,213 | 0% | |
| 3. | 5,606,394 | $218,705,430 | 0.01% | |
| 4. | 5,053,663 | $197,143,394 | 0% | |
| 5. | 4,484,263 | $174,931,100 | 0.01% |
News See All
10 Affordable Biotech Stocks to Buy Right Now
On July 6, BioPharma Dive reported that drug developers producing new medicines for the treatment of autoimmune disorders and cancer accounted for more than 40% of venture financing rounds in the first...
10 Resilient Stocks Beating Market Slump
International Business Machines saw its share prices climb by 5.04 percent on Tuesday to close at $264.94 apiece, after JPMorgan turned bullish for its stock, thanks to the rosy prospects for its software...
10 Best Mid-Cap Stocks That Could Double Your Money
In this article, we will take a look at some of the best mid-cap stocks that are currently offering at least 100% upside potential to investors. On June 13, CNBC reported that U.S.
10 Best Biotech Stocks with Highest Upside Potential
On April 16, reports from J.P. Morgan's biopharma and medtech venture and licensing studies indicated that the capital markets began the year 2026 with selective strength.
Is Viking Therapeutics, Inc. (VKTX) A Good Stock To Buy Now?
Is VKTX a good stock to buy? We came across a bullish thesis on Viking Therapeutics, Inc. on Charlie Evans’s Substack by Charlie Evans PhD.
20 Stocks Jim Cramer Wanted You To Sell & Immediately Get Out Of
As hostilities in Iran are restrained by a ceasefire, Jim Cramer has been busy discussing the current geopolitical climate and its impact on markets.
Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks
In an appearance on CNBC's Fast Money in January, Ray Stevens, CEO of Structure Therapeutics, discussed the unmet potential in the obesity market.
Is Viking Therapeutics (VKTX) One of the Shorted Biotech Stocks to Invest in
On February 12, Michael Ulz from Morgan Stanley reduced his price target on Viking Therapeutics Inc. (NASDAQ:VKTX) from $102 to $99.
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds
On February 5, J.P. Morgan shared its views on trends that are expected to define healthcare in 2026.
Hedge Fund Resource Center